CLINICAL_TRIALS
trial_result
· 2019-02-25
Clinical Trial Update: A Study of LY2090314 in Patients With Advanced or Metastatic Cancer [Phase 1]
Summary
Phase 1 study of LY2090314 in patients with advanced or metastatic cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED | Results posted: 2019-02-25